Deregulated lipid sensing by intestinal CD36 in diet-induced hyperinsulinemic obese mouse model

Marjorie Buttet, Helene Poirier, Veronique Traynard, Kevin Gaire, Thi Thu Trang Tran, Sinju Sundaresan, Philippe Besnard, Nada A. Abumrad, Isabelle Niot

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

The metabolic syndrome (MetS) greatly increases risk of cardiovascular disease and diabetes and is generally associated with abnormally elevated postprandial triglyceride levels. We evaluated intestinal synthesis of triglyceride-rich lipoproteins (TRL) in a mouse model of the MetS obtained by feeding a palm oil-rich high fat diet (HFD). By contrast to control mice, MetS mice secreted two populations of TRL. If the smaller size population represented 44% of total particles in the beginning of intestinal lipid absorption in MetS mice, it accounted for only 17% after 4 h due to the secretion of larger size TRL. The MetS mice displayed accentuated postprandial hypertriglyceridemia up to 3 h due to a defective TRL clearance. These alterations reflected a delay in lipid induction of genes for key proteins of TRL formation (MTP, L-FABP) and blood clearance (ApoC2). These abnormalities associated with blunted lipid sensing by CD36, which is normally required to optimize jejunal formation of large TRL. In MetS mice CD36 was not downregulated by lipid in contrast to control mice. Treatment of controls with the proteosomal inhibitor MG132, which prevented CD36 downregulation, resulted in blunted lipid-induction of MTP, L-FABP and ApoC2 gene expression, as in MetS mice. Absence of CD36 sensing was due to the hyperinsulinemia in MetS mice. Acute insulin treatment of controls before lipid administration abolished CD36 downregulation, lipidinduction of TRL genes and reduced postprandial triglycerides (TG), while streptozotocintreatment of MetS mice restored lipid-induced CD36 degradation and TG secretion. In vitro, insulin treatment abolished CD36-mediated up-regulation of MTP in Caco-2 cells. In conclusion, HFD treatment impairs TRL formation in early stage of lipid absorption via insulinmediated inhibition of CD36 lipid sensing. This impairment results in production of smaller TRL that are cleared slowly from the circulation, which might contribute to the reported association of CD36 variants with MetS risk.

Original languageEnglish
Article numberA63
JournalPloS one
Volume11
Issue number1
DOIs
StatePublished - Jan 4 2016

Fingerprint Dive into the research topics of 'Deregulated lipid sensing by intestinal CD36 in diet-induced hyperinsulinemic obese mouse model'. Together they form a unique fingerprint.

  • Cite this

    Buttet, M., Poirier, H., Traynard, V., Gaire, K., Tran, T. T. T., Sundaresan, S., Besnard, P., Abumrad, N. A., & Niot, I. (2016). Deregulated lipid sensing by intestinal CD36 in diet-induced hyperinsulinemic obese mouse model. PloS one, 11(1), [A63]. https://doi.org/10.1371/journal.pone.0145626